Please use this identifier to cite or link to this item:
標題: Regulation of tNOX expression through the ROS-p53-POU3F2 axis contributes to cellular responses against oxaliplatin in human colon cancer cells
作者: Chen, Huei-Yu
Islam, Atikul
Yuan, Tien-Ming
Chen, Shi-Wen
Liu, Pei-Fen
Chueh, Pin Ju
關鍵字: Apoptosis;Oxaliplatin;ROS;Sirtuin 1 (SIRT1);Tumor-associated NADH oxidase (tNOX or ENOX2);p53;Cell Line, Tumor;Colonic Neoplasms;Humans;NADH, NADPH Oxidoreductases;Oxaliplatin;Reactive Oxygen Species;Transfection;Tumor Suppressor Protein p53
Project: Journal of experimental & clinical cancer research : CR, Volume 37, Issue 1, Page(s) 161.
Oxaliplatin belongs to the platinum-based drug family and has shown promise in treating cancer by binding to DNA to induce cytotoxicity. However, individual patients show diverse therapeutic responses toward oxaliplatin due to yet-unknown underlying mechanisms. We recently established that oxaliplatin also exert its anti-cancer activity in gastric cancer cell lines by targeting tumor-associated NADH oxidase (tNOX), attenuate NAD+ generation and reduce NAD+-dependent sirtuin 1 (SIRT1) deacetylase activity, which in turn enhances p53 acetylation and apoptosis.
DOI: 10.1186/s13046-018-0837-9
Appears in Collections:生醫工程研究所

Files in This Item:
File Description SizeFormat Existing users please Login
344.pdf4.27 MBAdobe PDFThis file is only available in the university internal network    Request a copy
Show full item record

Google ScholarTM




Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.